Madrigal Pharmaceuticals, Inc.
MDGLNASDAQHealthcare● Active
$467.28
$-19.70(-4.05%)
Market Cap$10.8B
P/E Ratio—
52W High$615
52W Low$275
Madrigal Pharmaceuticals, Inc. (MDGL) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MDGL · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.98B | $0.93B | $0.63B | $0.36B | $0.27B |
| Net Receivables | $0.13B | $0.05B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.07B | $0.03B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $1.25B | $1.03B | $0.64B | $0.36B | $0.27B |
| PP&E Net | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $1.26B | $1.04B | $0.64B | $0.36B | $0.27B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.05B | $0.04B | $0.03B | $0.02B | $0.02B |
| Total Current Liabilities | $0.31B | $0.17B | $0.12B | $0.12B | $0.08B |
| Long-Term Debt | $0.35B | $0.12B | $0.12B | $0.05B | $0.00B |
| Total Liabilities | $0.66B | $0.29B | $0.24B | $0.17B | $0.08B |
| Stockholders Equity | |||||
| Retained Earnings | ($2.09B) | ($1.80B) | ($1.34B) | ($0.96B) | ($0.67B) |
| Total Stockholders Equity | $0.60B | $0.75B | $0.41B | $0.20B | $0.20B |
| Total Liab & Equity(computed) | $1.26B | $1.04B | $0.64B | $0.36B | $0.27B |
| Debt Summary | |||||
| Total Debt | $0.35B | $0.12B | $0.12B | $0.05B | $0.00B |
| Net Debt | $0.16B | $0.02B | $0.02B | ($0.28B) | ($0.04B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Madrigal Pharmaceuticals, Inc. data
About Madrigal Pharmaceuticals, Inc. (MDGL) Balance Sheet
Madrigal Pharmaceuticals, Inc. (MDGL) balance sheet shows total assets of $1.26B with cash of $0.98B. Total liabilities are $0.66B, total debt $0.35B, and stockholders equity $0.60B.
Frequently asked questions
MDGL · 4 questionsMadrigal Pharmaceuticals, Inc. has total debt of $0.35B with net debt of $0.16B.
MDGL total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10